FDA Drug Recalls

Recalls / Class II

Class IID-1538-2022

Product

Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

Affected lot / code info
Lot # J0636336-073022, J0637605-080422, Exp. date 08/31/2023

Why it was recalled

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Recalling firm

Firm
RemedyRepack Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
625 Kolter Dr Ste 4, Indiana, Pennsylvania 15701-3571

Distribution

Quantity
1,699 blister cards/30 tablets each
Distribution pattern
Distributed to two direct accounts in PA and AK.

Timeline

Recall initiated
2022-09-15
FDA classified
2022-09-15
Posted by FDA
2022-09-21
Terminated
2022-11-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1538-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.